Olumiant 2mg Tablet BARICITINIB
Introduction to Olumiant 2mg Tablet
Olumiant 2mg Tablet is a medication primarily used to treat certain autoimmune conditions. It is particularly effective for adults with moderate to severe rheumatoid arthritis who have not responded well to other treatments. Additionally, it is used in the management of COVID-19 in hospitalized adults requiring oxygen support and for severe alopecia areata, a condition that causes hair loss.
Composition of Olumiant 2mg Tablet
The active ingredient in Olumiant 2mg Tablet is Baricitinib. This compound works by inhibiting specific enzymes known as Janus kinases (JAKs), which play a role in the body's immune response and inflammation.
Uses of Olumiant 2mg Tablet
- Treatment of moderate to severe rheumatoid arthritis in adults.
- Management of COVID-19 in hospitalized adults requiring oxygen support.
- Treatment of severe alopecia areata in adults.
Side effects of Olumiant 2mg Tablet
Common side effects:
- Upper respiratory tract infections
- Nausea
- Headache
Serious side effects:
- Serious infections
- Blood clots
- Increased risk of cancer
Precautions of Olumiant 2mg Tablet
Olumiant should not be used in patients with active infections or severe liver impairment. It is also contraindicated during pregnancy. There is a risk of serious infections, increased risk of cancer, cardiovascular events, and blood clots. Caution is advised for elderly patients and those with a history of cardiovascular disease.
How to Take Olumiant 2mg Tablet
- Take the tablet once daily, with or without food.
- Try to take it at the same time each day for consistency.
- Follow your healthcare provider's instructions regarding dosage.
Conclusion of Olumiant 2mg Tablet
Olumiant 2mg Tablet is a valuable medication for managing certain autoimmune conditions and COVID-19 in specific cases. While it offers significant benefits, it is essential to be aware of potential side effects and precautions. Always consult with a healthcare professional before starting any new medication.







